Lactulose.
作者信息
Elkington S G
出版信息
Gut. 1970 Dec;11(12):1043-8. doi: 10.1136/gut.11.12.1043.
Abstract
摘要
相似文献
1
Lactulose.乳果糖
Gut. 1970 Dec;11(12):1043-8. doi: 10.1136/gut.11.12.1043.
2
[Lactulose treatment in three patients with chronic portal-systemic encephalopathy].[三例慢性门体性脑病患者的乳果糖治疗]
Naika Hokan. 1972 Apr;19(4):113-8.
3
Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.关于乳果糖治疗慢性肝性脑病患者效果的一些观察
Q J Med. 1970 Apr;39(154):245-63.
4
[Hepatic encephalopathy and its therapy with lactulose].
Policlinico Prat. 1971 Jun 15;78(12):509-14.
5
6
[Lactulose in the treatment of chronic portosystemic encephalopathies].[乳果糖在慢性门体性脑病治疗中的应用]
Cesk Gastroenterol Vyz. 1974 Apr;28(3):201-7.
7
Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
Am J Med. 1971 Aug;51(2):148-59. doi: 10.1016/0002-9343(71)90233-6.
8
[Treatment of chronic hepatic encephalopathy with lactulose (30 cases)].
Therapeutique. 1970 Jun-Jul;46(6):667-70.
9
Lactulose in liver failure.乳果糖在肝衰竭中的应用
Drug Ther Bull. 1970 Nov 6;8(23):89-90.
10
The many effects of lactulose: a rational approach to its therapeutic use.
Drugs. 1972;4(1):1-3. doi: 10.2165/00003495-197204010-00001.
引用本文的文献
1
Prevention and Health Benefits of Prebiotics, Probiotics and Postbiotics in Acute Lymphoblastic Leukemia.益生元、益生菌和后生元在急性淋巴细胞白血病中的预防作用及健康益处
Microorganisms. 2023 Jul 8;11(7):1775. doi: 10.3390/microorganisms11071775.
2
Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota.益生元作为预防和治疗肥胖和糖尿病的工具：分类和调节肠道微生物群的能力。
Int J Mol Sci. 2022 May 29;23(11):6097. doi: 10.3390/ijms23116097.
3
Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption.低剂量乳果糖作为益生元可改善肠道健康并增强矿物质吸收。
Front Nutr. 2021 Jul 27;8:672925. doi: 10.3389/fnut.2021.672925. eCollection 2021.
4
Lactulose-induced pneumatosis intestinalis following colonoscopy: a case report.结肠镜检查后乳果糖引起的肠气肿：一例报告。
Clin J Gastroenterol. 2021 Aug;14(4):1152-1156. doi: 10.1007/s12328-021-01392-9. Epub 2021 Mar 27.
5
Current and future pharmacological therapies for managing cirrhosis and its complications.管理肝硬化及其并发症的当前和未来药理学治疗方法。
World J Gastroenterol. 2019 Feb 28;25(8):888-908. doi: 10.3748/wjg.v25.i8.888.
6
L-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis.L-鸟氨酸L-天冬氨酸治疗肝硬化肝性脑病有效且安全。
J Clin Exp Hepatol. 2018 Sep;8(3):219-221. doi: 10.1016/j.jceh.2018.08.007. Epub 2018 Sep 5.
7
Pneumatosis coli after partial ligation of congenital portosystemic shunt in a dog.犬先天性门体分流部分结扎术后的结肠积气症
J Vet Med Sci. 2018 Nov 1;80(10):1549-1552. doi: 10.1292/jvms.18-0229. Epub 2018 Aug 17.
8
Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration.肝硬化患者的粪便细菌微生物群及乳果糖给药的影响。
BMC Gastroenterol. 2017 Nov 28;17(1):125. doi: 10.1186/s12876-017-0683-9.
9
Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition.《2015年修订版韩国慢性功能性便秘诊断和治疗指南》
J Neurogastroenterol Motil. 2016 Jul 30;22(3):383-411. doi: 10.5056/jnm15185.
10
Lactulose-induced pneumatosis intestinalis and pneumoperitoneum.乳果糖诱发的肠壁囊样积气症和气腹。
Dig Dis Sci. 2001 Nov;46(11):2549-53. doi: 10.1023/a:1012308911096.
本文引用的文献
1
An experimental malabsorption syndrome induced by neomycin.由新霉素引起的实验性吸收不良综合征。
Am J Med. 1960 Apr;28:524-33. doi: 10.1016/0002-9343(60)90146-7.
2
ACQUIRED MILK INTOLERANCE IN THE ADULT CAUSED BY LACTOSE MALABSORPTION DUE TO A SELECTIVE DEFICIENCY OF INTESTINAL LACTASE ACTIVITY.由于肠道乳糖酶活性选择性缺乏导致乳糖吸收不良引起的成人获得性乳糖不耐受。
Am J Med. 1965 Jan;38:7-30. doi: 10.1016/0002-9343(65)90156-7.
3
TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.嗜酸乳杆菌改变肠道菌群治疗肝性脑病
Lancet. 1965 Feb 20;1(7382):399-403. doi: 10.1016/s0140-6736(65)90002-4.
4
[STUDIES ON THE MECHANISM OF ACTION OF LACTULOSE (BETA-GALACTOSIDE ACTION OF LACTULOSE (BETA-GALACTOSIDO-FRUCTOSE) IN THE INTESTINE].乳果糖（β-半乳糖苷果糖）在肠道中的作用机制研究（乳果糖的β-半乳糖苷作用）
Klin Wochenschr. 1964 Feb 1;42:126-30. doi: 10.1007/BF01479054.
5
The existence of ammonia in blood in vivo with observations on the significance of the NH4 plus minus NH3 system.体内血液中氨的存在以及对NH₄⁺-NH₃系统意义的观察。
J Clin Invest. 1960 Feb;39(2):332-41. doi: 10.1172/JCI104044.
6
The role of pH gradient in the distribution of ammonia between blood and cerebrospinal fluid, brain and muscle.pH梯度在血液与脑脊液、脑与肌肉之间氨分布中的作用。
J Clin Invest. 1959 Feb;38(2):373-83. doi: 10.1172/JCI103811.
7
[Experimental alteration of fecal flora in healthy adults caused by eugalan capsules, lactose & Petuely's lactulose syrup].[由优加仑胶囊、乳糖及佩图利乳果糖糖浆引起的健康成年人粪便菌群的实验性改变]
Zentralbl Bakteriol Orig. 1958 Nov;173(1-2):76-96.
8
The passage of ammonia across the blood-brain-barrier and its relation to blood pH.氨通过血脑屏障及其与血液pH值的关系。
J Clin Invest. 1958 Dec;37(12):1724-8. doi: 10.1172/JCI103764.
9
Neomycin in the treatment of hepatic coma.新霉素治疗肝昏迷。
Lancet. 1957 Dec 21;273(7008):1262-8.
10
[The Lactobacillus bifidus factor].[双歧杆菌因子]
Dtsch Med Wochenschr. 1957 Nov 15;82(46):1957-60. doi: 10.1055/s-0028-1117025.
Zotero 插件